| ||
Valeant Pharmaceuticals Announces New Management Appointments Sacramento Bee MONTREAL, Nov. 28, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that Ryan Weldon and Jason Hanson will be named to Valeant's Executive Management Team. Mr. Weldon will assume ... See all stories on this topic » | ||
Cadence Pharmaceuticals Announces Settlement of OFIRMEV ... Sacramento Bee SAN DIEGO, Nov. 28, 2012 -- /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq: PRGO; TASE), and its subsidiary, Paddock ... See all stories on this topic » | ||
| ||
Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow ... Sacramento Bee GREENWOOD VILLAGE, Colo., Nov. 28, 2012 -- /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (AMPE), a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, ... See all stories on this topic » | ||
Par Pharmaceutical Begins Shipment of Generic Symbyax® The Herald | HeraldOnline.com 28, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ... See all stories on this topic » | ||
Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development ... Sacramento Bee SAN DIEGO, Nov. 28, 2012 -- /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has entered into a co-development and license agreement with Ildong Pharmaceutical Co., Ltd., for temanogrel, Arena's internally ... See all stories on this topic » | ||
| ||
REXAHN PHARMACEUTICALS, INC. : Teva Pharmaceutical to Increase ... 4-traders Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best-in-class oncology and central nervous system (CNS) therapeutics, today announced that Teva Pharmaceutical Industries Ltd. (Teva) ... See all stories on this topic » | ||
Stellar Pharmaceuticals Appoints Chief Scientific Officer to Support Growing ... Equities.com Dr. Chiasson was also employed by Bayer Healthcare Canada, a division of Bayer AG, a global pharmaceutical company with over $38 billion in revenues, as Director, Scientific Development Biologic, Products for Canada, as part of the Canada, Japan and ... See all stories on this topic » | ||
Sagent Pharmaceuticals Announces Launch of Nafcillin for Injection, USP NASDAQ SCHAUMBURG, Ill., Nov. 28, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Nafcillin for Injection, USP, in two vial presentations and one pharmacy bulk package bottle; all three are latex-free and ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment